Recombinant Human Resistin Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 1359-RN

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
1359-RN-005
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

E. coli

Accession #

Q9HD89

Conjugate

Unconjugated

Applications

Bioactivity

View all Resistin Proteins and Enzymes »

Product Specifications

Source

E. coli-derived human Resistin protein
Ser17-Pro108

Purity

>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ser17

Predicted Molecular Mass

9.7 kDa

SDS-PAGE

10 kDa, reducing conditions.

Activity

Bioassay data are not available.

Reviewed Applications

Read 2 reviews rated 5 using 1359-RN in the following applications:

Formulation, Preparation and Storage

1359-RN
Formulation Lyophilized from a 0.2 μm filtered solution in Acetic Acid.
Reconstitution
Reconstitute at 50 μg/mL in 2 mM acetic acid, pH 3.0.

Reconstitution Buffer Available:
Size / Price
Qty
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Resistin

Resistin (resistance-to-insulin), also known as adipocyte-specific secretory factor (ADSF) and found in inflammatory zone 3 (FIZZ3), is a 10 kDa member of a small family of secreted cysteine-rich peptide hormones. These molecules purportedly play some role in inflammation, glucose metabolism, and angiogenesis (1, 2, 3, 4). Human Resistin precursor is 108 amino acids (aa) in length. It contains an 18 aa signal sequence plus a 90 aa mature region. The mature region shows an N-terminal alpha-helical tail (aa 23 ‑ 44) and a C-terminal beta‑sheet globular head (aa 47 ‑ 108) (5 ‑ 7). The Resistin molecule circulates as either a noncovalent trimer (minor form), or a disulfide-linked homohexamer (major form). Noncovalent trimers are generated when the alpha-helical segments self-associate to form a three-stranded coiled-coil structure. Covalent hexamers subsequently appear when the free Cys at position # 26 is engaged by adjacent trimers. It is hypothesized that the hexamer is the inactive form of the molecule, and bioactivity is achieved at the target site by disulfide bond reduction (5). Although Resistin family molecules can noncovalently interact to form heterotrimers in vitro, there is no evidence to suggest this occurs in vivo with Resistin (8, 9). Mature human Resistin shares 56% and 54% aa identity with mouse and rat Resistin, respectively. Rat Resistin possesses an alternate start site at Met48; this Met is not found in the mouse molecule, however (10). Rodent Resistin is expressed by white adipocytes, splenocytes, astrocytes, and anterior pituitary epithelium (6, 11, 12). Although the function of Resistin is unclear, it would seem to block insulin-stimulated uptake of glucose by adipocytes and promote glucose release by hepatocytes (6, 13, 14). As such, it has been proposed to participate in diet‑induced insulin-sensitivity. Diets high in fat promote an increase in overall adipocyte size. Hypertrophic adipocytes are known to secrete TNF-alpha which acts locally to block ACRP30 production. Since ACRP30 is an insulin-sensitizer, a drop in ACRP30 availability leads to insulin-insensitivity, which drives increased insulin production (a compensatory mechanism). High insulin induces Resistin secretion which now antagonizes insulin action, prompting more insulin production and more Resistin secretion (15).

References

  1. Kottke, M.D. et al. (2006) J. Cell Sci. 119:797.
  2. Garrod, D.R. et al. (2002) Mol. Membrane Biol. 19:81.
  3. Leckband, D. and A. Prakasam (2006) Annu. Rev. Biomed. Eng. 8:259.
  4. King, I.A. et al. (1993) Genomics 18:185.
  5. Theis, D.G. et al. (1993) Int. J. Dev. Biol. 37:101.
  6. King, I.A. et al. (1996) J. Invest. Dermatol. 107:531.
  7. Nuber, U.A. et al. (1996) Eur. J. Cell Biol. 71:1.
  8. Chidgey, M. et al. (2001) J. Cell Biol. 155:821.
  9. Khan, K. et al. (2006) Br. J. Cancer 95:1367.
  10. Hashimoto, T. et al. (1997) J. Invest. Dermatol. 109:127.
  11. Caubet, C. et al. (2004) J. Invest. Dermatol. 122:1235.
  12. Descargues, P. et al. (2006) J. Invest. Dermatol. 126:1622.

Alternate Names

ADSF, FIZZ3, HXCP1, RETN

Entrez Gene IDs

56729 (Human); 57264 (Mouse)

Gene Symbol

RETN

UniProt

Q9HD89

Additional Resistin Products

Product Documents for Recombinant Human Resistin Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human Resistin Protein, CF

The purchase of this product conveys to the buyer the limited, non-exclusive, non-transferable right (without the right to resell, repackage, or further sublicense) to use these reagents for non-commercial research purposes only. No other license is granted to the buyer whether expressly, by implication, by estoppel or otherwise. In particular, the purchase of this product does not include nor carry any right or license to use, develop, or otherwise exploit this product commercially, which includes without limitation, provision of services to a third party, generation of commercial databases, clinical diagnostics or therapeutics, or drug development.

This product is manufactured under a license to U.S. Patent number 7,470,522. Any party desiring rights under this patent should contact Ryogen LLC, Montebello Park, 75 Montebello Road, Suffern, NY 10901.

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.